OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19) – GuruFocus.com
Posted: March 25, 2020 at 3:46 pm
ELMWOOD PARK, N.J., March 24, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for Miami residents by appointment.
BioReference is also announcing that they are providing testing for drive-through testing centers in South Florida, Hialeah and Hollywood through a collaboration with Larkin Community Hospital.
"We all are responsible for helping to control the spread of this virus," said Francis Suarez, Mayor of the City of Miami. "As an individual who tested positive for COVID-19, I have a duty to the City of Miami to bring my city's residents access to testing and information, and through our partnership with BioReference, we can help address this public health crisis."
"BioReference continues to prioritize expanding public access to COVID-19 testing across the nation," said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. "The importance of high-quality, reliable, scalable laboratory tests available is a critical part of the response in the effort to contain COVID-19."
If you demonstrate symptoms related with COVID-19, please call the Florida Department of Health immediately: 1-866-779-6121 or call the City of Miami COVID-19 Center: 1-305-960-5027.
Providers should refer to the most current CDC guidelines for further information on appropriate testing of patients, available here https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html.
About COVID-19 Testing at BioReference Laboratories, Inc.BioReference Laboratories is accepting specimens for COVID-19 testing from healthcare providers, clinics and health systems throughout the United States to promote earlier diagnosis of the coronavirus and to aid in limiting spread of infection. In addition to its nationwide COVID-19 testing offering, BioReference has partnerships with the New York State Department of Health, the New York City Health and Hospital Corporation (NYC Health + Hospitals), the State of New Jersey and the City of Detroit to provide COVID-19 testing.
BioReference is offering a real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay with expected 24-48 hour turnaround time. The Novel Coronavirus COVID-19 test has been made available pursuant to the U.S. Food and Drug Administration Emergency Use Authorization for diagnostic testing in CLIA certified high-complexity laboratories. All tests are conducted in BioReference's main laboratory in Elmwood Park, N.J., which currently has a capacity to run up to 15,000 COVID-19 tests per day. For more information, visit https://www.bioreference.com/coronavirus.
About BioReference Laboratories, Inc.BioReference provides comprehensive testing to physicians, clinics, hospitals, employers, government units, correctional institutions and medical groups. The company is in network with the five largest health plans in the United States, operates a network of 10 laboratory locations, and is backed by a medical staff of more than 160 MD, PhD and other professional level clinicians and scientists. For more information, visit http://www.bioreference.com.
About OPKO HealthOPKO Health is a diversified healthcare company. In diagnostics, its BioReference Laboratories is one of the nation's largest full-service clinical laboratories; GeneDx is a rapidly growing genetic testing business; the 4Kscore test is used to assess a patient's individual risk for aggressive prostate cancer following an elevated PSA and to help decide about next steps such as prostate biopsy; Claros 1 is a point-of-care diagnostics platform with a total PSA test approved by the FDA. In our pharmaceutical pipeline, RAYALDEE is our first pharmaceutical product to be marketed. OPK88003, a once-weekly oxyntomodulin for type 2 diabetes and obesity - reported positive data from a Phase 2 clinical trial. It's among a new class of GLP-1/glucagon receptor dual agonists. OPK88004, a SARM (selective androgen receptor modulator) is currently being studied for various potential indications. The Company's most advanced product utilizing its CTP technology, a once-weekly human growth hormone for injection, successfully met its primary endpoint and key secondary endpoints in a Phase 3 study and is partnered with Pfizer. OPKO also has research, development, production and distribution facilities abroad.
Cautionary Statement Regarding Forward-Looking StatementsThis press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding BioReference's plans to begin testing for COVID-19 in Miami and the timing of and availability of the test, the turn-around time for testing and test capacity, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in the OPKO Health, Inc. Annual Reports on Form 10-K filed and to be filed with the Securities and Exchange Commission and in its other filings with the Securities and Exchange Commission. In addition, forward-looking statements may also be adversely affected by general market factors, reagent and supply shortages, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA
View original content to download multimedia:http://www.prnewswire.com/news-releases/opko-healths-bioreference-laboratories-and-city-of-miami-provide-testing-for-coronavirus-disease-2019-covid-19-301028664.html
SOURCE BioReference Laboratories, Inc
See the original post:
OPKO Health's BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19) - GuruFocus.com
- What is Genetic Cancer Testing and How Do Patients Get Tested? - Curetoday.com - January 9th, 2021
- Preimplantation Genetic Testing Market - Global Growth, Trends, and Forecast to 2025: Major Players are The Cooper Companies, Illumina, Thermo Fisher... - January 9th, 2021
- Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer. - UroToday - January 9th, 2021
- Based on genes, nearly everyone is likely to have an atypical response to at least one drug - Scope - January 9th, 2021
- Color hits $1.5B valuation, plans to build on testing infrastructure - MedCity News - January 9th, 2021
- Preimplantation Genetic Testing Market Segments, Regional and Global Trends, Forecast and Competitive Landscape and Key Players -Inc. (US),... - January 9th, 2021
- Global Genetic Testing Market Forecasts for Applications and Technologies to 2025 - ResearchAndMarkets.com - Yahoo Finance - January 2nd, 2021
- Racial and ethnic disparities in germline genetic testing of patients with young-onset colorectal cancer - DocWire News - January 2nd, 2021
- The Top 5 Most-Read Precision Oncology Articles of 2020 - AJMC.com Managed Markets Network - January 2nd, 2021
- Stock Markets Sink, but These 2020 Stock Winners Look Good for the New Year - The Motley Fool - January 2nd, 2021
- How to Make 2021 Your Healthiest Year Yet - Sarasota - January 2nd, 2021
- These Were the 5 Top Genetics Stocks of 2020 - Motley Fool - January 2nd, 2021
- Genetic Testing Services Market Research Report is Projected to Witness Considerable Growth by 2026 - Farming Sector - January 2nd, 2021
- Predictive Genetic Testing and Consumer/Wellness Genomics Market Rear Excessive Growth During 2017 to 2025 - Farming Sector - January 2nd, 2021
- Predictive Genetic Testing Market Size 2020, Global Trends, Industry Share, Growth Drivers, Business Opportunities and Demand Forecast to 2025 -... - January 2nd, 2021
- Preimplantation Genetic Testing Market Size, Share, Growth Trends, Revenue, Top Companies, Regional Outlook, and Forecast, 2020-2027 - LionLowdown - January 2nd, 2021
- San Diego County ends 2020 with largest single-day COVID-19 death total of the year - The San Diego Union-Tribune - January 2nd, 2021
- Direct Genetic Testing for Consumer Market is expected to show impressive growth rate between 2020 to 2026 - LionLowdown - January 2nd, 2021
- Hey, soldiers and spies think twice about that home genetic ancestry test - Roll Call - December 26th, 2020
- Population Testing for Hereditary Breast and Ovarian Cancer Worthwhile? - Medscape - December 26th, 2020
- $2 million settlement reached in lawsuit against ob-gyn office in Norwich - theday.com - December 26th, 2020
- Genetic Testing Market is Rapid Growing with COVID-19 Impact Analysis, Top Key Companies Abbott Laboratories, Bio-Rad Laboratories Inc., Competitive... - December 26th, 2020
- Toddler who received heart transplant due to get baby brother - Newsday - December 26th, 2020
- Impact of COVID-19 on Pre-Pregnancy Genetic Testing Market 2027 Expected to reach Highest CAGR - The Courier - December 26th, 2020
- DTC Genetic Testing Market Size By Type, By Application, By Geography, By Top Companies And Forecast To 2027 - LionLowdown - December 26th, 2020
- Breast Cancer Predictive Genetic Testing Market Likely to Experience a Tremendous Growth in Near Future|| Roche, Thermo Fisher Scientific,... - December 26th, 2020
- Prenatal Genetic Testing Market Key Trends, Strategic Indicators, Drivers, SWOT, Key Participants and Global Industry Overview and Key Players Natera... - December 24th, 2020
- Class action launched against Monash IVF over non-invasive embryo testing - ABC News - December 24th, 2020
- Science Talk - Being told I had the BRCA2 mutation effectively saved my life Tony's story - The - The Institute of Cancer Research - December 24th, 2020
- Predictive Genetic Testing Market Business Opportunities, Leading Players, Trends Outlook Up to 2025Agilent, Technologies, Inc., BGI Genomics,... - December 24th, 2020
- Publication Reveals in Side-by-Side Comparison that Method Using PacBio Sequencing Detects Only 72% of the Large Structural Variants Detected by... - December 24th, 2020
- Global DTC Genetic Testing Market Growth Graph To Demonstrate Inclination Towards Positive Axis By 2026 - The Courier - December 24th, 2020
- Insights on the Genetic Testing Global Market (2021 to 2025) - Updated for COVID-19 Pandemic Impact - GlobeNewswire - December 22nd, 2020
- Researcher to test value of tailored gene testing - WA Health - December 22nd, 2020
- Latin American Patients with Lung Cancer and Native American Ancestry See Increased EGFR Mutations - Cancer Network - December 22nd, 2020
- 'For us, it was just an instant warm connection:' 5 siblings to unite for the first time - KXLH Helena News - December 22nd, 2020
- Preimplantation Genetic Testing Market 2020 Top Countries Market Analysis and Opportunity Assessment 2025 Research Report - Farming Sector - December 22nd, 2020
- 4 Women Share The Role Genetic Testing Played in Their Breast Cancer Treatment - Oprah Mag - December 21st, 2020
- Genetic Analysis Services Market: Uptake of Next-generation Sequencing and Multi-gene Tests to Drive Market - BioSpace - December 21st, 2020
- Clinical Utility of GBinsight Comprehensive Genetic Testing Showcased at the 2020 National Lipid Association's Scientific Sessions - PR Web - December 21st, 2020
- Moving Genomics to the Clinic - World Economic Forum - December 21st, 2020
- Sask. woman who got stomach removed to thwart cancer describes life with 'ticking time bomb' - CBC.ca - December 21st, 2020
- Elite Testing and Wellness Launches Innovative DNA Testing and IV Therapy in the Atlanta Market - PRNewswire - December 21st, 2020
- Oklahoma researchers looking for additional patients across the US with rare genetic mutation - KFOR Oklahoma City - December 21st, 2020
- Invitae: Network Strategy And Industry Tailwinds Should Offer Path To Profitability - Seeking Alpha - December 21st, 2020
- Reimagining mental healthcare from the ground up - Stanford Today - Stanford University News - December 21st, 2020
- A look at the diagnostics chapter of precision medicine - MedCity News - December 21st, 2020
- Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing - Business Wire - December 9th, 2020
- Genetic disease in India: more prevalent than previously thought? - Hyderus Cyf - December 9th, 2020
- Point-of-Care Genetic Testing Market Size, Analysis, Regional Outlook, Competitive Strategies and Forecasts to 2027 - Cheshire Media - December 9th, 2020
- Local Announcement: Why I did Genetic Testing - NEW Breast of Everything Podcast - Patch.com - November 20th, 2020
- New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients - Yahoo Finance - November 20th, 2020
- Outlook on the Direct-to-Consumer Genetic Testing Global Market to 2025 - Featuring Genetic Technologies, Illumina & Myriad Genetics Among Others... - November 20th, 2020
- Direct-to-Consumer Genetic Testing: Global Markets and Technologies - GlobeNewswire - November 20th, 2020
- CancerIQ Officially Launches Lab Network to Increase Awareness and Accelerate Adoption of Genetic Testing - PR Web - November 20th, 2020
- Mayo Clinic study finds 1 in 8 patients with cancer harbor inherited genetic mutations - Greater Milwaukee Today - November 20th, 2020
- Small Covid Test Maker Is Going Viral - TheStreet - November 20th, 2020
- Genome Medical Reaches 90 Million Covered Lives in US - PRNewswire - November 20th, 2020
- Molecular Testing With Universal Method Comparable to Traditional Method in Hereditary Solid Tumors - Targeted Oncology - November 20th, 2020
- Global DTC Genetic Testing Market 2020 Comprehensive analysis with Top Manufacturers, Trends, Share, Future Growth Opportunities & Forecast by... - November 20th, 2020
- Global Preimplantation Genetic Testing Market Is Booming Globally | Most recent Report with Analysis | Future Possibility | Coronavirus Effect and... - November 20th, 2020
- Preimplantation Genetic Testing Market Outlook and Opportunities in Grooming Regions with Forecast to 2027 - The Daily Philadelphian - November 20th, 2020
- Genetic Testing Market by Size, Covid-19 Impact, Competitive Strategy, Worldwide Growth Insights, Regional Trends, Segmentation and Forecast to 2024 -... - November 20th, 2020
- Covid 19 Analysis On Direct-to-Consumer Genetic Testing Devices Market Growth in Business Future Scenarios and Brief Analysis of Top Key Players |... - November 20th, 2020
- Myriad Genetics Announces Global Expansion of Myriad myChoice Tumor Testing in Europe and China - GlobeNewswire - November 20th, 2020
- Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for... - November 10th, 2020
- Rare Disease Genetic Testing Market Analysis, COVID-19 Impact,Outlook, Opportunities, Size, Share Forecast and Supply Demand 2021-2027|Trusted... - November 10th, 2020
- The Value of a Molecular Diagnosis of Epilepsy - Medical Device and Diagnostics Industry - November 10th, 2020
- Pre-Pregnancy Genetic Testing Market : Drivers, Restraints, Opportunities, and Threats (20202025) - The Think Curiouser - November 10th, 2020
- The Implications of the Growing Role of Genetic TestingLecture by Anthropologist Rayna Rapp, Nov. 11 - NYU News - November 10th, 2020
- Global Preimplantation Genetic Testing Market: In-depth Analysis of Market Share, Size, Segmentaion, Top Players across the Region and Globe, Current... - November 10th, 2020
- Direct-to-Consumer Genetic Testing (DTC-GT) Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis... - November 10th, 2020
- Preimplantation Genetic Testing Market Analysis, Size, Market Trends, Latest Technology and Cost Structures with Future Forecasts to 2027 - PRnews... - November 10th, 2020
- Increasing Government Investments and Favorable Policies to Aid the Growth of the Predictive Genetic Testing Market 2019 2029 - Eurowire - November 10th, 2020
- Axovant Gene Therapies Announces FDA Clearance of IND for AXO-AAV-GM2 Gene Therapy in Tay-Sachs and Sandhoff Diseases - GlobeNewswire - November 10th, 2020
- Top Scenario: Direct-to-Consumer Genetic Testing Market 2020 to Witness Excellent Long-Term Growth Outlook Report by ResearchDive - The Think... - November 10th, 2020
- Dr. Rohs on the Importance of Genetic Testing in NSCLC - OncLive - November 8th, 2020
- Genetic Testing Can Lead to Precision Medicine Therapies for Cancer - HealthITAnalytics.com - November 8th, 2020
- One in Eight Cancer Patients Harbors Inherited Mutation that Increases Risk of Disease Development - Clinical OMICs News - November 8th, 2020
- How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial - DocWire... - November 8th, 2020